HYFT

MindWalk Holdings Corp. Common Stock (HYFT)

Stock · NASDAQ · Health Care

$1.31as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

HYFT pivots to recurring AI revenue as ReefIQ seeks to offset losses. MindWalk Holdings announced a strategic shift toward recurring revenue from artificial‑intelligence services. The company highlighted its ReefIQ platform as a way to counteract widening losses in other areas. This change signals a focus on more stable cash flow streams, which could influence future financial performance. Investors may watch how quickly the new model generates consistent income.

Active signals

Support level
$1.3
Industry
Biotechnology: Pharmaceutical Preparations

What HYFT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike42-4.9%45%
Bollinger Band Breakdown23+1.6%52%
Bollinger Band Breakout18-3.8%33%
200-Day Moving Average TouchActive now9-8.1%33%
Any 20-session window (baseline)-4.2%40%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About HYFT

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered i…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
74

Fundamentals

1-day range
$1.34$1.4
Market cap
$59.79M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-0.37
Dividend yield
—
Beta
0.77
Avg. volume
240.3K
Dividend pay date
November 23, 2020
52-week range
$0.99$2.99
Next earnings: December 15, 2026 · EPS estimate $-0.06confirmed

Forecasts

3 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$5
+281.7%
Median
$5
+281.7%
Low
$3
+129.0%

MindWalk Holdings Corp. Common Stock Competitors

Chosen by industry and closest market cap.

  • HYFT
    MindWalk Holdings Corp. Common Stock
    $1.31
    ▼ 6.43%
    Market cap $59.79MP/E —
    $0.99$2.99
  • DWTX
    Dogwood Therapeutics Inc. Common Stock
    $1.22
    ▼ 2.40%
    Market cap $58.85MP/E —
    $1.24$7.04
  • PMVP
    PMV Pharmaceuticals Inc. Common Stock
    $1.21
    ▼ 6.20%
    Market cap $62.93MP/E —
    $1.02$1.91
  • BOLD
    Boundless Bio Inc. Common Stock
    $2.34
    ▼ 0.43%
    Market cap $63.80MP/E —
    $0.9612$3.16
  • IMMP
    Immutep Limited American Depositary Shares
    $3.2
    ▼ 0.31%
    Market cap $55.21MP/E —
    $0.022$0.47
  • ANVS
    Annovis Bio Inc. Common Stock
    $0.99
    ▼ 5.71%
    Market cap $64.44MP/E —
    $1.01$5.5
  • INCR
    Intercure Ltd. Ordinary Shares
    $4.57
    ▼ 1.72%
    Market cap $54.80MP/E —
    $253.3$2,740

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.